Articles

Lilly asks judge to reject U.K. Zyprexa case

Eli Lilly and Co., the Indianapolis-based drugmaker whose best-selling schizophrenia medicine Zyprexa survived a patent challenge in Britain two years ago, has asked a United Kingdom judge to reject a parallel lawsuit by a generic drug company.

Read More

Rolls-Royce upgrades engine on market since 1950s

Rolls-Royce’s Indianapolis plant assembles few of its workhorse T56 aircraft engines in whole, but cranking out spare parts for overhauls is a large business. The last contract modification, issued by the U.S. Air Force in 2007, is worth up to $789 million and is still active.

Read More

Emmis selling three major radio stations

Emmis Communications Corp. has reached an agreement to sell three big-market radio stations to a partnership involving a private equity firm and a prominent media executive, the company disclosed Tuesday morning.

Read More

WellPoint pays big to tap fast-growing Medicare market

Analysts raised their eyebrows at the $800 million reportedly paid by WellPoint Inc. to acquire a West Coast Medicare plan, but with the commercial health insurance business stagnating, Medicare is vital to WellPoint’s future growth.

Read More

Federal judge dismisses Brightpoint fraud suit

A London-based hedge fund sued Brightpoint over a $10 million loan it alleged the Indianapolis-based mobile phone distributor fraudulently brokered in anticipation of an acquisition that never materialized.

Read More

WellPoint paying almost $800M for CareMore

Indianapolis-based WellPoint Inc. agreed to acquire CareMore Health Group to expand Medicare coverage in California, Arizona and Nevada. The insurer paid almost $800 million, according to people familiar with the deal.

Read More

Total pay for executives surged in 2010

Total executive compensation at Indiana’s largest public companies continued to rise sharply coming out of the recession, even though many of them have yet to erase the red ink in their shareholders’ portfolios.

Read More